Category
Primary
cancer · embed-ft 0.58
Tree path
Medical Health › Diseases and Conditions › Cancer
Group (tier-1)
Tech stack
CMS
Analytics
CDN
Framework
Consent/CMP
AI readiness
AI training policy
allowed
Terms of Service
found · https://anktiva.com/legal-notice
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
FDA-approved Immunotherapy Treatment for NMIBC CIS - ANKTIVA®
Description
ANKTIVA® is the first FDA-approved drug for non-muscle invasive bladder cancer that activates natural killer cells, T cells, & memory T cells. Learn more now.
Final URL
Language
en (html)
Scanned at
2026-06-18 17:56:57